Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

  

Tim Fell (Chief Operating Officer)   Board member

Tim FellFollowing his D.Phil in Semiconductor Materials Tim migrated to the biological sciences in 1992 to work with DNA microarray pioneer Prof Ed Southern at Oxford University. In 1999 he co-founded Oxford Gene Technology (Operations) Ltd where as Technical Director, and later as General Manager, he developed a DNA microarray fee-for-service business.

 

In 2002 UK anti-infective drug discovery company Arrow Therapeutics Ltd acquired the business and he joined the management team as CTO. His last role was with the London Technology Network, which he joined in 2005 as a Technology Consultant with a remit to stimulate collaboration between global business and the academic research base in the South East of England. 

 

Tim has an MBA from the London Business School.  

 

He joined CellCentric in March 2006.